午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频
ShangHai Biochempartner Co.,Ltd
Firmenname:
ShangHai Biochempartner Co.,Ltd
Telefon:
177-54423994
E-Mail:
2853530910@QQ.com
Nationalit?t:
China
URL:
www.biochempartner.com
Produkte insgesamt:
7972
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
Produktkatalog
BMS-191011
202821-81-6
C16H10ClF3N2O3
NGB2904
189060-98-3
C28H29Cl2N3O
Apolizumab
267227-08-7
JTE-607 dihydrochloride
188791-09-5
C25H32Cl3N3O5
Pax2 inhibitor EG1
693241-54-2
C22H18N2O5
Lenacapavir
2189684-44-2
C39H32ClF10N7O5S2
NNMTi
42464-96-0
C10H11N2.I
ICCB-19 HCl
1803605-68-6
C12H22ClN3OS
NSC 2805
4371-34-0
C14H14O4
2-(Pyrrolidin-1-yl)acetic acid hydrochloride
6628-74-6
C6H12ClNO2
LM11A-31 dihydrochloride
1243259-19-9
C12H26ClN3O2
(2S,1'R,2'S)-N-(tert-butoxycarbonyl)-2-(1'-hydroxy-2'-Methyl-3'-butenyl)-pyrrolidine
159173-40-7
C14H25NO3
AAL-993
269390-77-4
C20H16F3N3O
CC-885
1010100-07-8
C22H21ClN4O4
UoS12258
875927-64-3
C17H19FN2O2S
IT-603
292168-90-2
C11H9BrN2O3S
iBET-BD1
2451862-42-1
C30H33N5O3
SCO-267
1656261-09-4
C36H46N4O5
MIPS521
1146188-19-3
C19H10ClF6NOS
ARP100
704888-90-4
C17H20N2O5S
Foravirumab
944548-38-3
Pascolizumab
331243-22-2
Siplizumab
288392-69-8
AZ10606120 dihydrochloride
607378-18-7
C25H34N4O2.2HCl
CRT-0066101
956121-30-5
C18H19ClN4O
dupilumab
1190264-60-8
ONC206
1638178-87-6
C23H22F2N4O
Giredestrant tartrate
2407529-33-1
C31H37F5N4O7
Narsoplimab
2108782-45-0
Dup-721
104421-21-8
C14H16N2O4
Bisindolylmaleimide VIII Acetic Acid Salt
138516-31-1
C24H22N4O2
Hydroxyibuprofen
51146-55-5
C13H18O3
N-(2-Aminoethyl)-2-(2,6-dichlorophenoxy)propanamide
344443-16-9
C11H14Cl2N2O2
ONC-212
1807861-48-8
C24H23F3N4O
VAL083
23261-20-3
C6H10O4
CL-82198
307002-71-7
C17H22N2O3
Ethyl 8-amino-4-oxo-4H-chromene-2-carboxylate
103195-35-3
C12H11NO4
TNKS656
1419949-20-4
C27H34N4O5
JFD01307SC
51070-56-5
C6H11NO4S
Amatuximab
931402-35-6
Zinpyr-1
288574-78-7
C46H36Cl2N6O5
Cedelizumab
156586-90-2
RVX297
1044871-04-6
C24H29N3O4
SRS16-86
1793052-96-6
C26H32N4O2
((2-Fluoro-6-(methoxymethoxy)-8-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)naphthalen-1-yl)ethynyl)triisopropylsilane
2621932-37-2
C29H42BFO4Si
Pimethixene
1-Methyl-4-(9H-thioxanthen-9-yliden)piperidin
314-03-4
C19H19NS
CP-31398 Dihydrochloride Hydrate
1217195-61-3
C22H26N4O
PU-H54
1454619-13-6
C18H19N5S
Pimethixene maleate
1-Methyl-4-(9H-thioxanthen-9-yliden)piperidiniumhydrogenmaleat
13187-06-9
C23H23NO4S
PF-05231023
1037589-69-7
C26H32N4O8
CC90010
1706738-98-8
C21H21NO4S
Senaparib
1401682-78-7
C24H20F2N6O3
LY 2979165
1311385-35-9
C13H17N5O5S
Efalizumab
214745-43-4
MCP110
521310-51-0
C33H36N2O3
BTTAA
1334179-85-9
C19H30N10O2
HJC0197
1383539-73-8
C19H21N3OS
Tolebrutinib
1971920-73-6
C26H25N5O3
Indirubin-3'-oxime
667463-82-3
C16H11N3O2
AZD-0284
2101291-07-8
C21H18F6N2O5S
MT802
2231744-29-7
C41H41N9O8
NI-42
1884640-99-6
C18H15N3O3S
Simufilam
1224591-33-6
C15H21N3O
Lintuzumab
166089-32-3
N-[4-(6-Fluoro-3,4-dihydro-2(1H)-isoquinolinyl)-2,6-dimethylphenyl]-3,3-dimethylbutanamide
1009344-33-5
C23H29FN2O
IWP-4
686772-17-8
C23H20N4O3S3
Spongosine
24723-77-1
C11H15N5O5
(6R)-FR054
35954-65-5
C14H19NO8
Gevokizumab
1129435-60-4
Galloflavin
568-80-9
C12H6O8
GSK840
2361146-30-5
C21H23N3O3
Siltuximab
541502-14-1
LM11A-31
289475-77-0
C12H25N3O2
JNJ67856633
2230273-76-2
C20H11F6N5O2
HT-61
936622-80-9
C26H24N2O
Dot1L-IN-4
2565705-02-2
C28H27ClF2N8O5S
sulfopin
2451481-08-4
C11H20ClNO3S
LQZ-7I
195822-23-2
C20H14F2N4
((4S,5S)-Cy2-Ubaphox)Ir(COD)]BARF
880262-14-6
C77H67BF24IrNO2P
Felvizumab
167747-20-8
Pexelizumab
219685-93-5
HPK1-IN-7
2320462-65-3
C24H22N6O4
5-hydroxy-3,9-dimethyl-7H-benzo[c]fluoren-7-one
80826-37-5
C19H14O2
JHN76359
1715076-35-9
C25H19NO4S2
Meplazumab
2413715-21-4
1-(2-Methoxy-5-methylphenyl)ethanone
20628-07-3
C10H12O2
Bisindolylmaleimide IV
119139-23-0
C20H13N3O2
CLK-IN-T3
2109805-56-1
C28H30N6O2
CAROVERINE
23465-76-1
C22H27N3O2
Caroverine hydrochloride
55750-05-5
C22H27N3O2
PIM1-IN-1
1417630-95-5
C25H30N8O2
(S)-2,2-Dimethyl-cyclopropanecarboxylic acid ethyl ester
89007-61-4
C8H14O2
Rafivirumab
944548-37-2
Visilizumab
219716-33-3
RG7834
2072057-17-9
C22H27NO6
PTI-125 hydrochloride
2480226-07-9
C15H22ClN3O
2H-Indol-2-one, 1,3-dihydro-3-(4-hydroxyphenyl)-3-[4-(trifluoromethoxy)phenyl]-7-(trifluoromethyl)-, (3S)-
2407860-34-6
C22H13F6NO3
Motavizumab
677010-34-3
Labetuzumab
219649-07-7
CITCO
338404-52-7
C19H12Cl3N3OS
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
Copyright 2019 ? ChemicalBook. All rights reserved